Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:E72 (4 October), doi:10.1136/bmjusa.01100004 (published 13 September 2002)
This article originally appeared in BMJ USA
EditorOnce again I read an article about a treatment I use commonly, which gives an equivocal opinion about its effectiveness. Despite the conclusion that there are insufficient data on which to base a recommendation to give shoulder corticosteroid injections, I continue to find them invaluable. It is easy for researchers to take away what many GPs find as effective treatment and leave us to pick up the piecesshoulder pains that do not respond to physiotherapy, persons with contraindications to nonsteroidal therapy, and working patients who do not have time for physiotherapy. How are we to deal with these patients knowing that we have helped hundreds of others in the past with a treatment that has "no good evidence"?
Graeme Mackenzie, general practitioner
Maryport, Cumbria, UK graeme.mackenzie{at}GP-A82032.nhs.uk
EditorThe statement that sepsis is reported in up to 1 in 17 joint or soft tissue injections is presumably a misprint. The usual figure is 1 in 17 000.1
Steve Longworth, GP Principal
The East Leicester Medical Practice, Leicester, UK Longworth_S{at}gp-C82063.nhs.uk